STAGE IIIB LUNG CANCER AJCC V8
Clinical trials for STAGE IIIB LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIB LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIB LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat cancers, but study ends early
Disease control TerminatedThis early-phase study tested a drug called plinabulin combined with radiation and immunotherapy in 19 people with advanced cancers (like lung, bladder, or melanoma) that had stopped responding to standard immunotherapy. The goal was to see if the combo could shrink tumors or slo…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:15 UTC
-
Lung cancer study tests immunotherapy-chemo combo after standard treatments fail
Disease control TerminatedThis study tested whether adding the immunotherapy drug bintrafusp alfa to standard chemotherapy (docetaxel) helps people with advanced non-small cell lung cancer whose disease worsened after prior treatment with immunotherapy and chemotherapy. The trial planned to enroll 10 adul…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Cancer combo trial halted early: what we learned
Disease control TerminatedThis early-stage trial tested a new immunotherapy drug (BMS-986218) combined with another immunotherapy (nivolumab) and precise radiation for people with advanced solid tumors that had spread. The goal was to see if the combination was safe and could shrink tumors. The study was …
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:40 UTC